OMDA
Omada Health, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$19.65
+2.45%Year over year
Reported trailing growth
- Revenue
- +47.6%
- EBITDA
- +145.3%
- EBIT
- +98.4%
- EPS
- +111.7%
- Free cash flow
- +198.0%
- Operating cash flow
- +226.7%
Forward estimates
Based on analyst estimates
- Revenue
- +25.3%
- EBITDA
- +215.3%
- EPS
- +367.8%
Three-year CAGR
- Revenue
- +42.9%
- EBITDA
- +87.4%
- EBIT
- +72.6%
- Net income
- +72.9%
- EPS
- +74.1%
- Free cash flow
- +144.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026